At our heart, Magellan Health is a clinically-centered, academically-influenced, data and evidence-driven organization with deep expertise in addressing special populations and complex care needs. That clinical heart drives everything that we do — our insights, our services and our solutions. Our Clinical staff contribute to both internal and external publications, you can explore some of their work below.
Looking for Magellan’s Leadership team? You can find more information here
If you would like to speak with one of Magellan’s Clinical team, please contact Media Relations here
Dr. Caroline Carney is a board-certified internist and a board-certified psychiatrist. She joined Magellan Health in 2016 and serves as Magellan Health’s Chief Medical Officer, while continuing as chief medical officer for Magellan Rx Management. Her previous experience includes the role of SVP Chief Medical Officer of Magellan Behavioral Health and Magellan Specialty Health. She served as the chief medical officer for regional health plans where she gained experience in Medicaid, Medicare, Exchange, and commercial populations. She has served as the medical director for the Indiana Office of Medicaid Policy and Planning, helping to launch the Medicaid expansion product as well as the behavioral health transformation for the state’s community mental health services. While in Indiana, she served on the Governor’s Mental Health Commission. She is a frequent speaker about behavioral health services, integrated and collaborative care, and the importance of self-care during the pandemic. Dr. Carney is a published author and co-author for over 100 peer and non-peer reviewed publications focusing on issues surrounding comorbid medical and behavioral health conditions. She was a tenured associate professor of Internal Medicine and Psychiatry at Indiana University. She started her medical and academic career at the University of Iowa where she earned her medical degree, as well as a master’s degree, and directed the Med-Psych residency program. She continues to engage in regular clinical work through supporting the behavioral health team at a federally qualified health center.
Yagnesh has been with Magellan for over 4 years, in managed care for 5 years, and was a clinician in the field of Behavior Analysis for 11 years prior. Yagnesh has over 16 years experience in ABA, starting off by working directly with individuals on the autism spectrum to directing programs in homes, schools, and community based settings. Currently, as the Vice President of Autism for Magellan, Yagnesh oversees both the autism and ABA product for Magellan nationally. His team of BCBAs and licensed clinicians provide a unique experience in ABA UM as they all have similar experience to Yagnesh with real-world experience. Yagnesh also engages in the decision making process for ABA both at Magellan and nationally, with participation in work groups such as ICHOM, speaking at conferences and universities, and developing outcomes measures for the field of ABA.
Dr. Rebecca Borgert is the Director of Clinical Oncology Product Development at Magellan Rx Management. In this role, Dr. Borgert focuses on developing, implementing and coordinating comprehensive oncology products and solutions for health plan clients. She is responsible ensuring achievement of program goals and continuously analyzing clinically sound program enhancements. She is a Board Certified Oncology pharmacist with clinical experience in pediatric oncology, adult ambulatory oncology, bone marrow transplantation and palliative care/hospice care. She is a graduate of the University of Florida College Of Pharmacy.
Steve Cutts is the senior vice president and general manager of specialty at Magellan Rx, leading sales, account management, operations and product development across the division and delivers solutions to help clients successfully manage complex specialty pharmaceuticals in one of the fastest growing areas of healthcare spending. Steve began his career as a retail pharmacist and transitioned to managed care in 2010. Steve earned a Doctor of Pharmacy from University of Rhode Island and serves as Adjunct Clinical Assistant Professor of Pharmacy Practice at URI, mentoring 6th year pharmacy students as a preceptor. He is a registered pharmacist in the state of Rhode Island.
Dr. Steven Pratt is the senior medical director for the employer segment within Magellan Healthcare. He joined Magellan Healthcare in 2017 and previously served as the executive medical director of behavioral health for the Minnesota Department of Human Services (MN DHS). In his current role, Pratt is responsible for clinical oversight of utilization management, case management, and a unique disability management program. His expertise is relied upon in product development, quality oversight and contract management for the employer segment. In addition to extensive experience in leadership of public sector, direct care organizations, he has previous health plan experience working for United Health Group (UNH). At United Health he was involved in development of disease management and health advocacy programs. Pratt has a deep interest in cost containment through wellness promotion and integrative care. He is adept at leading organizational change, engaging individuals who are not engaged in change efforts and holding all, including himself, accountable to the highest standards of performance. He has a breadth of experience as a public speaker and trainer with particular interest in what he and the MN DHS termed “The Core Four” evidence-based practices: Person-centered Culture, Motivational Interviewing, Trauma Informed Care and Positive Behavior Supports. Pratt earned his medical degree and bachelor’s degree from the University of Minnesota.
Dr. Haita Makanji joined Magellan Rx Management in 2014. She is currently the vice president of clinical strategy and innovation within specialty in which she assumes several roles and responsibilities, including development and management of specialty clinical programs and interfacing with payers and pharmaceutical companies to bring unique solutions to curb the rising specialty spend. For clinical program development and management, she is responsible for design, implementation, and day-to-day operations of specialty programs that improve the quality of care for patients with high cost disease states including but not limited to rheumatoid arthritis, multiple sclerosis, oncology, and rare diseases such as hemophilia. Furthermore, she oversees the MRx Comprehensive Oncology Management Program which encompasses utilization management with unique strategies to curb the rising spend in oncology and complex case management. A significant portion of her role has also expanded to lead clinical program development efforts for other lines of business including employer groups and Medicaid plans. Additionally, Dr. Makanji leads a team of pharmacists, including board-certified oncology pharmacists who are tasked to support payers and assist with comprehensive medical and pharmacy data analyses, prior authorization and medical policy design, and organizing unique key opinion leader thought leadership panels. Dr. Makanji has been in the healthcare industry for over 10 years. She began her career as a HIV-certified pharmacist at Walgreens and transitioned to managed care in early 2012 with CDMI, LLC (which was later acquired by Magellan Rx Management in 2014). Dr. Makanji earned a Doctor of Pharmacy from Massachusetts College of Pharmacy and Health Sciences in Boston, MA. She is currently a registered pharmacist in both Rhode Island and Connecticut and has additional advanced training in HIV from University of Buffalo, and medication therapy management and immunizations from the American Pharmacists Association (APhA). Dr. Makanji also serves as president of the Northeast affiliate of the Academy of Managed Care Pharmacy (AMCP).